Cornerstone Wealth Group LLC trimmed its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 83.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,341 shares of the healthcare conglomerate's stock after selling 12,194 shares during the period. Cornerstone Wealth Group LLC's holdings in UnitedHealth Group were worth $730,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of UNH. Bayforest Capital Ltd increased its stake in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after buying an additional 50 shares during the period. O Brien Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after buying an additional 37 shares during the period. Kentucky Trust Co boosted its holdings in shares of UnitedHealth Group by 138.5% in the first quarter. Kentucky Trust Co now owns 93 shares of the healthcare conglomerate's stock valued at $49,000 after buying an additional 54 shares during the period. Finally, Nova Wealth Management Inc. boosted its holdings in shares of UnitedHealth Group by 339.1% in the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate's stock valued at $53,000 after buying an additional 78 shares during the period. 87.86% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Several research firms have recently weighed in on UNH. Cantor Fitzgerald reiterated an "overweight" rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. JPMorgan Chase & Co. increased their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a report on Thursday, October 9th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Mizuho increased their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an "outperform" rating in a report on Thursday, October 9th. Finally, Bank of America increased their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a "neutral" rating in a report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Hold" and an average price target of $384.09.
Check Out Our Latest Analysis on UNH
UnitedHealth Group Price Performance
Shares of UNH opened at $359.70 on Wednesday. The firm has a market capitalization of $325.77 billion, a PE ratio of 15.58, a PEG ratio of 2.32 and a beta of 0.47. The company's 50-day moving average is $322.74 and its 200-day moving average is $347.08. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the previous year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.